- Glaucoma in Conjunction with Cataract
- Stand Alone Glaucoma
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size was valued at USD 635.4 million in 2023 and is poised to grow at 5.9% CAGR during 2024-2030. Minimally Invasive Glaucoma Surgery (MIGS) devices are advanced medical devices designed to treat glaucoma with less tissue trauma compared to traditional glaucoma surgeries. These devices aim to lower intraocular pressure (IOP) in the eye by improving the outflow of aqueous humor, thereby preventing further optic nerve damage and vision loss. The increasing prevalence of glaucoma in the elderly population drives demand for MIGS devices. Moreover, patients and surgeons prefer minimally invasive options due to quicker recovery times and fewer complications which enhances the market growth.
However, MIGS devices and procedures can be expensive, limiting their accessibility in some regions. Also, the need for specialized training to perform MIGS limits its widespread adoption. Ongoing research and development can lead to the introduction of more effective and affordable MIGS devices which is an opportunity for the market growth.
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Key Developments:
- In 2022: Glaukos received FDA clearance for the iStent Infinite Trabecular Micro-Bypass System.
- In 2020: The FDA approved the iStent inject® W, an advanced trabecular micro-bypass stent designed for primary open-angle glaucoma. This approval marked a significant milestone in providing patients with a safer, minimally invasive treatment option.
Minimally Invasive Glaucoma Surgery Devices Market Summary
Study Period
2024-2030Base Year
2023CAGR
5.9%Largest Market
North-AmericaFastest Growing Market
North-AmericaMinimally Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
The global glaucoma market is growing because to factors like the ageing population, rising rates of glaucoma, increased demand for operations combining glaucoma and cataracts, and heightened attention from major manufacturers in the MIGS stent development. Additionally, AbbVie bought Allergan plc in 2019 acquired eye care products such as Xen, Durysta, Ozurdex, and Refresh/Optive. With these remarkable improvements, regional firms are vying for market share in minimally invasive glaucoma surgery devices. As a result, the market is growing faster as MIGS devices are adopted more widely. The lack of qualified specialists and reimbursement constraints for MIGS devices, however, are impeding market expansion. Furthermore, the quick switch from glaucoma drugs to minimally invasive glaucoma operations present an opportunity for the growth of the MIGS device industry. Moreover, advancements in technology have brought about a revolutionary shift in the management of glaucoma through minimally invasive glaucoma surgery (MIGS). The development of novel stent technologies, such as the iStent inject® W by Glaukos Corporation, has significantly enhanced the safety and efficacy of MIGS procedures. These stents are designed to be implanted with minimal tissue disruption, facilitating better aqueous humor outflow and lowering intraocular pressure effectively.
North-America Got Significant Share of
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis
North America, particularly the United States, has a well-established healthcare system with high adoption rates of advanced medical technologies. For instance, according to the American Academy of Ophthalmology, glaucoma affects over 3 million Americans, driving the demand for effective treatments. The US government and regulatory bodies, such as the FDA, support the development and approval of innovative medical devices, facilitating market growth. Whereas, Europe is found to be fastest growing market.
Latin America
Europe
Asia Pacific
Middle East
North America
Minimally Invasive Glaucoma Surgery Devices Market Segmentation
By Surgery
By Target
- Trabecular Meshwork
- Suprachoroidal Space
- Others
By Product
- MIGS Stents
- MIGS Shunts
- Others
By End User
- Eye Hospitals
- Ophthalmology Clinics
- Outpatient Surgical Centres
Frequently Asked Questions
MIGS devices are used to lower intraocular pressure in patients with glaucoma by improving the outflow of aqueous humor in a minimally invasive manner.
MIGS procedures are preferred because they involve less tissue trauma, quicker recovery times, and fewer complications compared to traditional surgeries.
Glaukos Corporation received FDA approval in 2020 for the iStent inject® W, a trabecular micro-bypass stent.
North America is leading the market due to its advanced healthcare infrastructure, high prevalence of glaucoma, and supportive government policies.
The main challenges include high costs, lack of skilled professionals, and stringent regulatory requirements.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Minimally Invasive Glaucoma Surgery Devices Market Introduction |
| 2.1.Global Minimally Invasive Glaucoma Surgery Devices Market - Taxonomy |
| 2.2.Global Minimally Invasive Glaucoma Surgery Devices Market - Definitions |
| 2.2.1.Surgery |
| 2.2.2.Target |
| 2.2.3.Product |
| 2.2.4.End-user |
| 2.2.5.Region |
| 3.Global Minimally Invasive Glaucoma Surgery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Minimally Invasive Glaucoma Surgery Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Minimally Invasive Glaucoma Surgery Devices Market By Surgery, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Glaucoma in Conjunction with Cataract |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Stand Alone Glaucoma |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Minimally Invasive Glaucoma Surgery Devices Market By Target, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Trabecular Meshwork |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Suprachoroidal Space |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Minimally Invasive Glaucoma Surgery Devices Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. MIGS Stents |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. MIGS Shunts |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Minimally Invasive Glaucoma Surgery Devices Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Eye Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Ophthalmology Clinics |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Outpatient Surgical Centres |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Minimally Invasive Glaucoma Surgery Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Surgery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Glaucoma in Conjunction with Cataract |
| 10.1.2.Stand Alone Glaucoma |
| 10.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Trabecular Meshwork |
| 10.2.2.Suprachoroidal Space |
| 10.2.3.Others |
| 10.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.MIGS Stents |
| 10.3.2.MIGS Shunts |
| 10.3.3.Others |
| 10.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Eye Hospitals |
| 10.4.2.Ophthalmology Clinics |
| 10.4.3.Outpatient Surgical Centres |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Surgery Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Glaucoma in Conjunction with Cataract |
| 11.1.2.Stand Alone Glaucoma |
| 11.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Trabecular Meshwork |
| 11.2.2.Suprachoroidal Space |
| 11.2.3.Others |
| 11.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.MIGS Stents |
| 11.3.2.MIGS Shunts |
| 11.3.3.Others |
| 11.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Eye Hospitals |
| 11.4.2.Ophthalmology Clinics |
| 11.4.3.Outpatient Surgical Centres |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Surgery Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Glaucoma in Conjunction with Cataract |
| 12.1.2.Stand Alone Glaucoma |
| 12.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Trabecular Meshwork |
| 12.2.2.Suprachoroidal Space |
| 12.2.3.Others |
| 12.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.MIGS Stents |
| 12.3.2.MIGS Shunts |
| 12.3.3.Others |
| 12.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Eye Hospitals |
| 12.4.2.Ophthalmology Clinics |
| 12.4.3.Outpatient Surgical Centres |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Surgery Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Glaucoma in Conjunction with Cataract |
| 13.1.2.Stand Alone Glaucoma |
| 13.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Trabecular Meshwork |
| 13.2.2.Suprachoroidal Space |
| 13.2.3.Others |
| 13.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.MIGS Stents |
| 13.3.2.MIGS Shunts |
| 13.3.3.Others |
| 13.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Eye Hospitals |
| 13.4.2.Ophthalmology Clinics |
| 13.4.3.Outpatient Surgical Centres |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Surgery Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Glaucoma in Conjunction with Cataract |
| 14.1.2.Stand Alone Glaucoma |
| 14.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Trabecular Meshwork |
| 14.2.2.Suprachoroidal Space |
| 14.2.3.Others |
| 14.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.MIGS Stents |
| 14.3.2.MIGS Shunts |
| 14.3.3.Others |
| 14.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Eye Hospitals |
| 14.4.2.Ophthalmology Clinics |
| 14.4.3.Outpatient Surgical Centres |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Alcon Inc. |
| 15.2.2.ALLERGAN PLC. |
| 15.2.3.Corza Ophthalmology |
| 15.2.4.ELLEX MEDICAL LASERS LTD. |
| 15.2.5.Glaukos Corporation. |
| 15.2.6.IRIDEX Corporation |
| 15.2.7.ISTAR MEDICAL SA |
| 15.2.8.IVANTIS INC. |
| 15.2.9.Lumenis Be Ltd. |
| 15.2.10.NOVARTIS INTERNATIONAL AG |
| 15.2.11.Ziemer Ophthalmic Systems AG |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Alcon Inc.
- ALLERGAN PLC.
- Corza Ophthalmology
- ELLEX MEDICAL LASERS LTD.
- Glaukos Corporation.
- IRIDEX Corporation
- ISTAR MEDICAL SA
- IVANTIS INC.
- Lumenis Be Ltd.
- NOVARTIS INTERNATIONAL AG
- Ziemer Ophthalmic Systems AG